Description: - A unique collection of 2394 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;- Targets include Bcl-2, Caspase, p53, TNF-alpha, and surviving, etc.;- Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA;- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;- Structurally diverse, medicinally active, and cell permeable;- NMR and HPLC validated to ensure high purity and quality;